Loading
Breast medical oncologist from Gustave Roussy who chairs the board of France's Institut National du Cancer.
Suzette Delaloge is Chair (Présidente) of the Board of Directors of the Institut National du Cancer (INCa), the French national cancer agency, appointed in 2026. A medical oncologist at Gustave Roussy, she has led major breast cancer research including the MyPeBS trial of risk-based breast screening and Gustave Roussy's cancer prevention programme.
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, breast cancer.
Shares Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares Institut National du Cancer and the tags leadership, cancer policy.